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Abstract
Circular RNAs (circRNAs) are covalently closed RNA molecules that have been linked to various diseases, including cancer.
However, a precise function and working mechanism are lacking for the larger majority. Following many different
experimental and computational approaches to identify circRNAs, multiple circRNA databases were developed as well.
Unfortunately, there are several major issues with the current circRNA databases, which substantially hamper progression
in the field. First, as the overlap in content is limited, a true reference set of circRNAs is lacking. This results from the low
abundance and highly specific expression of circRNAs, and varying sequencing methods, data-analysis pipelines, and
circRNA detection tools. A second major issue is the use of ambiguous nomenclature. Thus, redundant or even conflicting
names for circRNAs across different databases contribute to the reproducibility crisis. Third, circRNA databases, in essence,
rely on the position of the circRNA back-splice junction, whereas alternative splicing could result in circRNAs with different
length and sequence. To uniquely identify a circRNA molecule, the full circular sequence is required. Fourth, circRNA
databases annotate circRNAs’ microRNA binding and protein-coding potential, but these annotations are generally based on
presumed circRNA sequences. Finally, several databases are not regularly updated, contain incomplete data or suffer from
connectivity issues. In this review, we present a comprehensive overview of the current circRNA databases and their
content, features, and usability. In addition to discussing the current issues regarding circRNA databases, we come with
important suggestions to streamline further research in this growing field.
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Introduction
After their discoverymore than three decades ago, circular RNAs
(circRNAs) have been emerging as a large class of generally non-
coding RNAs. Originating from the same precursor as linear RNA
transcripts, circRNAs are formed through a process called back-
splicing, in contrast to regular forward splicing. Back-splicing
results in a covalently closed loop characterized by a nonlin-
ear back-spliced junction (BSJ) between a splice donor and an
upstream splice acceptor, and lacking a poly(A) tail and 5′ and 3′
ends. Due to their circular nature, circRNAs are more resistant
to degradation by exonucleases and therefore, more stable than
linear RNA [1,2]. CircRNAs are widespread and abundant in
a variety of organisms. It is estimated that the total number
of circRNA molecules is roughly 1% of the number of poly(A)
molecules [3]. Generally, the expression levels of most circRNAs
is estimated to be 5–10% of their corresponding linear RNA
product [4]. Interestingly, the majority of circRNAs seem to be
cell-type specific [3,5].
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Although the function of most circRNA remains largely
unknown, increasing evidence shows that circRNAs can act as a
sponge formicroRNAs (miRNA) and RNA binding proteins (RBPs),
as modulator of transcription and splicing, and as template for
translation [6,7]. Furthermore, circRNAs have been associated
with a broad range of diseases, including various types of cancer
[8,9]. Here, circRNAs have been found to act as miRNA sponges
to inhibit their regulation of downstream cancer target genes.
CircCDR1as and circMTO1, for example, bind to miR-7 and miR-
9, respectively, and influence gene regulation, thus indirectly
achieving either tumor inhibition or stimulation [10,11]. Due
to the observed associations between circRNA abundance and
cancer, circRNAs may serve as cancer biomarkers with good
diagnostic performance [12].
Various studies also demonstrated that circRNAs are present
at relatively high steady state levels in human biofluids, such
as saliva, plasma, serum and in exosomes, which makes them
attractive candidate biomarkers for noninvasive liquid biopsies
[1]. For example, circ-ZEB1.33 was overexpressed in hepatocel-
lular carcinoma (HCC) compared to adjacent normal tissue and
normal liver. In line with this, the serum level of circ-ZEB1.33
was higher in HCC patients compared to healthy controls, and its
levels in HCC tissue and serum were correlated across different
TNM stages (TNM Classification of Malignant Tumors) and were
associated with overall survival in HCC patients [13].
Numerous bioinformatics pipelines have been developed to
identify circRNAs [14–17], leading to the prediction of millions
of circRNAs in different short read RNA-sequencing (RNA-
seq) datasets [2,3,18,19]. This spurred in the development of
more than 20 databases containing human circRNAs. These
databases also contain various circRNA annotations, such
as circRNA tissue- and disease-specificity, circRNA–miRNA
interactions, circRNA–RBP interactions, circRNA coding potential
and conservation amongst species. Each has its unique aspects
and merits, but we are far off a uniform consensus circRNA
catalog. In this review, we present a comprehensive overview of
the current circRNA databases and their content, features and
usability. Furthermore, we discuss the current issues regarding
circRNA databases and come with important suggestions to
streamline further research in this growing field.
Material and methods
Literature search
PubMed and Google were queried with the following keywords:
‘circRNA database’, and all relevant hits were inspected man-
ually. To keep the focus of our analyses on circRNA databases,
only databases specific for circRNAs were included in the result
tables. Other databases with interesting features are mentioned
in the text. Databases exclusively containing plant circRNAs [20]
were not included in this review.
Data acquisition
All circRNAdatabasewebsiteswere visited on 03 September 2019
using Google Chrome, Firefox and Safari.
When available, database exports were downloaded.
Data processing
Database content was processed in RStudio (v1.2.1335). All
databases containing circRNA coordinates based on the hg38
genome build were converted to hg19 using LiftOver (UCSC
Genome Browser [21]). We noticed that the start positions in
the files obtained from circAtlas v2.0 were one nucleotide
off compared to the other databases. To compensate for this
issue, the start of each BSJ in circAtlas v2.0 was lowered by one
nucleotide.
The number of unique circRNAs in each database was cal-
culated based on the BSJ or based on the unique name for the
noncurated and curated databases, respectively.
Euler plots were generatedwith CRAN package Eulerr (v5.1.0).
It is important to note that while Euler plots are a very helpful
vizualisation, there is always some error, and the higher the
number of diagrams, the higher the error. To ensure correct
interpretation of the plots, all Euler plot results are also reported.
The overlap between circRNA databases was calculated based
on the BSJ position. As not all databases report the strand from
which the circRNA originates, circRNAswere compared solely on
their BSJ position.
The number of single-exon circRNAs was calculated by com-
paring the BSJ positions with all exon positions (downloaded
from Ensembl, GRCh37 archive [22]).
Results
Overview of human circRNA databases
In total, we selected 20 human circRNAs databases and divided
them into two categories: noncurated databases, based on in-
house or publicly available RNA-seq or circRNA datasets; and
curated databases, based on literature searches for empirically
validated circRNA (Tables 1 and 2; Supplemental Table 1).Despite
several attempts,Circ2Traits, CircInteractome,CircNet and deep-
Base v2.0 were unreachable, and therefore not included in some
of our analyses. In addition, CircR2Disease and circRNADb were
often found to be unreachable.
All curated circRNA databases employ the same content
search strategy, namely a literature search with keywords
such as ‘circular RNA’ and ‘circRNA disease’, followed by
manual selection of suitable articles. Interestingly, apart from
circRNA validation, Circ2Disease also includesmanually curated
circRNA–miRNAs interactions, circRNA–RBP interactions and
other up- or down-stream regulatory genes.
While most circRNA databases predominantly store human
circRNAs, a few databases also include other species such as fly,
worm and mouse (Figure 1). TSCD claims to contain circRNAs
detected in macaque samples but these data are currently not
present in the database. Interestingly, the number of circRNAs
varies substantially across the databases. In addition, each cir-
cRNA database provides different types of circRNA annotations,
which are described in the following paragraphs.
CircRNA annotation
To facilitate functional exploration of circRNAs, circRNA
databases typically include several annotation levels. This
section contains a short description of these annotations; a
complete overview of circRNA annotations can be found in
Supplemental Table 1.
Tissue-specificity
CircRNAs are generally annotated as tissue-specific if they are
detected in specific tissues or cell types, sometimes assessed
by a specificity score. CircAtlas v2.0, CIRCpedia v2 and TCSD all
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Table 1. Characteristics of noncurated circRNA databases. (A) Noncurated databases that were online accessible (B) Noncurated databases that
were not online accessible
Database Dataset # circRNAs∗ Detection tool(s) Filter Short description
A
circAtlas v2.0 [23] In-house data 610,406 CIRI2, DCC,
MapSplice,
CircExplorer2
≥2 tools ≥2 BSJ
reads
Detection of circRNAs in 17 human
tissues reports conservation across
species, circRNA-microRNA
interaction, predicted ORF, IRES and
RBP sites
circbank [24] Public circRNA
dataset (circBase)
140,725 Does not apply Unknown Focus on nomenclature system; reports
miRNAs binding sites, conservation
across species, m6A modification,
mutations in circRNA, predicted ORFs
and IRES sites
circBase [25] Public circRNA
datasets
92,375 Depends on source None Unified database of all circRNAs
predicted by nine large-scale studies;
reports putative spliced circRNA
sequences
CIRCpedia v2 [26] Public RNA-seq
datasets
177,456 CIRCexplorer2,
MapSplice
Unknown Focus on circRNAs in 65 human cell
lines
CircRiC [5] Pubic RNA-seq
datasets
92,599 CIRI2, find_circ,
CIRCexplorer2,
circRNA_finder
≥2 tools ≥2BSJ
reads
Focus on detection of lineage-specific
circRNAs in 935 cancer cell lines;
reports drug response, biogenesis,
interactions between circRNAs and
mRNA (including miRNAs), proteins,
or mutations
circRNADb [27] Public circRNA
datasets
32,914 Depends on source ≥2 BSJ reads Focus on protein-coding annotation
(predicted ORFs with protein-coding
potential and evidence by mass
spectrometry; reports exon splicing
information and predicted IRE sites
CSCD [11] Public RNA-seq
datasets
1,223,114 CIRI2, find_circ,
circRNA_finder,
CIRCexplorer
None Focus on distinguishing cancer-specific
circRNAs from ‘normal’ circRNAs in 87
cancer cell lines and 141 normal cell
lines; reports circRNA-miRNA
interactions, putative splicing
possibilities, predicted cellular
location, RBP sites and ORFs
exoRBase [28] Public blood
exosomal
RNA-seq datasets
57,412 ACFS, find_circ ≥2 tools Focus on circRNA, IncRNA and mRNA in
human blood exosomes
MiOncoCirc v2.0 [8] In-house data 227,056 CIRCexplorer ≥2 BSJ reads circRNA detection in 2093 clinical
human cancer samples using exome
capture sequencing
TSCD [29] Public RNA-seq
datasets
284,296 CIRI, find_circ,
circRNAfinder
≥2 BSJ reads Tissue-specific circRNAs in 16 adult
human tissues and 15 fetal human
tissues; reports circRNA-miRNA
interactions, conservation across
species and predicted RBP sites
B
Circ2Traits [30] Public circRNA
dataset
1953∗∗ find_circ ≥2 BSJ reads Association of circRNAs with diseases
based on the interactions of circRNAs
with disease-associated miRNAs and
disease-associated SNPs mapped on
circRNA loci
CircInteractome [31] Public circRNA
dataset (circBase)
Unknown Does not apply Unknown Focus on interaction between miRNAs
and circRNAs with RBP sites; reports
IRES sites and ORFs
CircNet [32] Public RNA-seq
datasets
34,000∗∗ find_circ ≥3 sources Maps circRNA–miRNA–mRNA
interactions into regulatory networks
deepBase v2.0 [33] Public RNA-seq and
circRNA datasets
(circBase)
14,867∗∗ find_circ Unknown Comparison of (small) noncoding RNAs
(including circRNAs) across 19 species;
reports conservation between species
∗Number of unique human circRNAs in the download files.
∗∗Number of human circRNAs reported by the authors; this could not be verified as the database was not online.
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Table 2. Characteristics of curated circRNA databases
Database # circRNAs∗ Validation method∗∗ Articles prior to Short description
Circ2Disease [34] 249 RT-(q)PCR microarray 01 November 2017 Reports curated circRNA-disease and
circRNA-miRNA association
Circad [35] 925 Unknown Unknown Reports curated circRNA-disease
associations, including detailed experimental
validation
CircFunBase [36] 3181 RT-(q)PCR microarray
RNA-seq
01 May 2018 Reports circRNA-associated miRNAs and
circRNA-associated RBPs (CircInteractome)
in seven plants and eight animals,
including humans
CircR2disease [37] 599 RT-qPCR microarray 31 March 2018 Reports curated circRNA-disease associations
CircRNADisease [38] 328 RT-qPCR microarray
RNA-seq
01 November 2017 Reports curated circRNA-disease associations
LncRNADisease 2.0 [39] 736 RT-(q)PCR microarray 31 May 2018 Reports curated circRNA-disease associations
∗Number of unique human circRNAs in the download files.
∗∗Most circRNAs in the database are validated by at least one of these methods. Some rarely used methods were omitted for clarity.
report circRNA expression levels across various human tissues
and cell lines. In addition, CircRiC focuses on circRNAs in cancer
cell lines and MiOncoCirc v2.0 on circRNAs in clinical human
cancer samples.
CircRNA-disease associations
Due to their potential use as biomarkers, there has also been
increasing interest in the association of circRNAs with diseases.
These associations are mostly reported by curated databases,
where circRNAs are considered disease-specific when up- or
downregulated in a particular disease sample. circRNADb is a
noncurated circRNA database that also reports circRNA-disease
associations if there is a link between the parental gene of the
circRNA and a specific disease.
CircRNA–miRNA interactions
In total, 12 of the databases discussed in this review (60%)
report circRNA–miRNA interactions. To predict miRNA binding
sites in circRNA sequences, MiRanda [40] and/or TargetScan
[41] are often used. CircAtlas v2.0, circBase and circRNADisease
also provide circRNA–miRNA interactions, without mentioning
whichmiRNA database was used or how these interactions were
predicted.
CircRNA–RBP interactions
In total, six circRNA databases (35%) report circRNA–RBP inter-
actions. CircInteractome, CircRiC, CSCD and TSCD predict cir-
cRNA–RBP interactions based on crosslinking immunoprecipi-
tation sequencing (CLIP-seq) data from starBase v2.0 [42]. The
remaining two, CircFunBase and Circ2Disease, use the predicted
RBP–circRNA interactions from CircInteractome (unfortunately
offline).
Protein-coding potential
Although circRNAs are generally classified as noncoding RNAs,
eukaryotic ribosomes can initiate translation of engineered cir-
cRNA when containing an internal ribosome entry site (IRES)
element [26]. Furthermore, several human circRNAs are shown
to be translated in vivo [43]. Therefore, some databases report
predicted IRES or predicted open reading frames (ORFs). circR-
NADb provides the richest information on the protein-coding
potential of circRNAs. It contains predicted IRES elements in
the spliced sequence of each circRNA using VIPS (viral IRES
prediction system) [44], and it also predicts the longest potential
ORF. Other circRNA databases rely on CPAT (coding-potential
assessment tool) [45] or ORF Finder (from NCBI), and IRESfinder
[46] or IRESite [47] to predict the coding potential and IRES
elements, respectively.
CircRNA conservation
As conservation of a particular genomic sequence may hint
at a functional role, multiple researchers have investigated the
conservation of circRNAs. CircAtlas v2.0, circbank and CIRC-
pedia v2 classify circRNAs from different species as orthologs
when the BSJ site is conserved within a small 2–5 nucleotide
range.
Other annotations
Finally, some circRNA databases have unique annotation
features. For example, CircRiC reports the correlation between
host gene expression and normalized BSJ read numbers.
Furthermore, CircRiC also includes associations between
drug response and the expression of circRNAs. MiOncoCirc
v2.0 developed a pipeline (CODAC) to identify back-splicing
involving two genes. Additionally, multiple databases report
putative circRNA functions based on gene ontology enrichment
analysis.
Discussion
There is little overlap among public circRNA databases
In total, 20 databases were included in this review, of which
14 noncurated and six curated. To assess the overlap among
the circRNA databases, Euler plots were generated (Figure 2 and
Supplemental Table 2).
The noncurated databases (Figure 2A) were divided into two
groups, either based on de novo generated circRNA data or based
on publicly available circRNA datasets (distinction also indicated
in Table 1). First, for the databases that use publicly available cir-
cRNA datasets (circbank, circBase, circRNADb, CircInteractome,
deepBase v2.0), we expect to see a high degree of overlap, as they
often reuse the same datasets. While circbank, CircInteractome
and deepBase v2.0 all use the circBase circRNA dataset as input,
the contents of CircInteractome and deepBase v2.0 could not
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Figure 1. There is substantial variation in the number of circRNAs across databases. Number of unique circRNAs in the (A) noncurated and (B) curated databases.
Most databases solely contain human circRNAs, but some also include circRNAs detected in other species. The number of circRNAs differs greatly between and within
noncurated and curated databases. The differences within noncurated circRNA databases can mostly be explained by different starting material, sequencing method,
circRNA detection tools and filtering steps. The differences within curated databases can partly be explained by different selection criteria of empirically validated
circRNAs, despite similar search strategies.
be assessed, as their databases were not online. Furthermore,
although circBase completely overlaps with circbank, somehow
circbank contains more circRNAs than circBase, an observation
we were unable to find an explanation for. circBase itself is
based on nine circRNA datasets, including Jeck et al. [18] and
Memczak et al. [19], two circRNA datasets that are also included
in circRNADb (based on four datasets in total). Next, for the
databases that use in-house or publicly available RNA-seq data
(circAtlas v2.0, CIRCpedia v2, CircRiC, CSCD, exoRBase, MiOn-
coCirc v2.0 and TSCD), we observe little overlap. This is not
unexpected as these databases rely on different samples, and
circRNAs are expressed at low levels and with high sample-
specificity [3,5]. Additionally, these circRNA databases applied
different sequencing methods (varying RNA input levels, library
preparation, sequencing dept, all affecting the sensitivity of the
circRNA detection), circRNA detection tools and filtering steps,
further contributing to the difference in content between the
noncurated circRNAdatabases.The overlap betweennoncurated
databases increases when filtered for experimentally validated
circRNAs (circRNAs present in at least one curated database),
as this also increases the probability of true positive circRNAs
(Supplemental Figure 1).
It is thus extremely important to considerwhat sampleswere
used to build the circRNA database and select a database in line
with the tissue of interest. Moreover, the detection of circRNA
in RNA-seq data does not guarantee that the predicted circRNAs
are true positives. Therefore, some databases allow filtering for
circRNAs detected by at least two tools, which improves the
reliability of the predictions [48].
Overall, noncurated circRNA databases seem to contain a
high number of circRNAs, whereby the reliability of these circR-
NAs must be questioned, as no validation using an orthogonal
method is reported. Besides, it is important to recognize that cir-
cRNA expression and detection can vary considerably depending
onmultiple factors such as sample type, sequencingmethod and
circRNA detection tool.
Six databases were found containing curated circRNA dis-
ease or function associations. Combined, these databases add
up to 3522 circRNAs that have been empirically validated to
date (Supplemental Table 3). Despite similar search strategies,
there are notable differences in the content of curated databases
(Figure 2B). Of note, not all databases apply the same crite-
ria to label circRNAs as empirically validated. For the unpub-
lished database circad, there is no information available on
the accepted validation methods. Overall, the curated databases
accept circRNAs validated by reverse transcriptase (quantita-
tive) polymerase chain reaction (RT-(q)PCR),microarray or north-
ern blot. However, CircFunBase and circRNADisease also accept
RNA-seq as a sufficient method of circRNA validation. Seven
hundred and forty four out of 3181 (23%) and 17 out of 328
(5%) circRNAs were solely detected by RNA-seq, respectively. It
is not reported if a circRNA enrichment step (e.g. using RNAse
R) was used as part of the RNA-seq validation, moreover both
RNA-seq with and without circRNA enrichment can be found in
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Figure 2. Varying degrees of overlap among circRNA databases. To assess the content of circRNA databases, the overlap within (A) noncurated and within (B) curated
databases was calculated. First, all non-hg19-based databases were converted to hg19 using LiftOver (UCSC Genome Browers [21]), and subsequently a Euler plot was
computed. Of note, while an Euler plot is helpful for vizualisation, it is not entirely accurate and the plotted overlap is the approximation with the smallest error. For
example, 35% of circRNAs present in CircRiC are also present in at least one of the other noncurated databases, however it was not possible to show this in the Euler
plot. The exact overlap between all circRNA databases can be consulted in Supplemental Table 2.
the validated circRNAs whenmanually inspected. As a universal
method for circRNA validation is lacking, we urge researchers
to be more cautious and rely on multiple detection methods for
effective validation of circRNAs.
Another explanation for the limited overlap between curated
databases could be the redundancy arising from misannotated
chromosomal positions. Usually, coordinates (chr:start-end) are
given with inclusive start and end position. However, some
formats (such as Browser Extensible Data, BED format) use a
0-based exclusive start position. Uncareful curation of circRNA
positions from literature could thus result in incorrect or even
redundant annotation. For example, there are two nearly iden-
tical CDR1 circRNAs present in CircFunBase, one with posi-
tion chrX:139865340-139866824, and the other one with posi-
tion chrX:139865339-139866824 (both hg19). The former is only
supported by one publication, in contrast to the latter, which is
supported by multiple publications and is also present in other
databases (hsa_circ_0001946). However, these are probably the
same molecules with BSJ positions based on different annota-
tion systems.
In total, there are more than 2 million different circRNAs
present in the union of all noncurated databases (compared
to 384,066 predicted human RNA transcripts [49]), and 3522
circRNAs in the union of all curated databases. Surprisingly,
more than 500 curated circRNAs are not present in any of the
noncurated databases. This can partly be explained by misan-
notated start positions, as was previously discussed for CircFun-
Base. Although this issue does not completely explain these 500
circRNAs solely detected in curated databases, we expect that
the remaining loss in overlap is due to other annotation related-
issues. It is therefore recommended, when comparing datasets,
to ensure that the annotations are compatible, or adjust them if
necessary.
Further illustration of the lack in overlap can be seen in
Supplemental Figure 2,which shows thatmost circRNAs are only
present in one database.
The full-length sequence of circRNAs is lacking
Multiple databases (30%) provide full-length circRNA sequences
and use it to predict interactions with miRNA and other
sequence-based interaction partners. Unfortunately, the full-
length sequence of most circRNAs is not known to date as
full-length length circRNA sequencing datasets are lacking.
Rather, the sequence between the start and stop position of the
circRNA is inferred based on the reference genome sequence.
The databases seem to report full-length circRNA sequences
based on all known exons from the linear transcript. Most
databases remove the introns, with the exception of circAtlas
v2.0, which reports circRNA sequences based on exons and
introns. This, however, relies on the unsupported assumption
that circular and linear transcripts share the same splicing
pattern and RNA sequence. However, almost 50% of the circRNA
host genes give rise to multiple (up to 20) circular isoforms each
[50]. Additionally, the inferred circRNA sequence depends on
the genome build and on the exon and transcript annotation.
CircFunBase reports multiple full-length circRNA sequences
based on all overlapping linear transcripts reported by Ensembl,
without taking into account alternative splicing.
In fact, all the databases included in this review should rather
be called BSJ databases instead of circRNA databases, as none
of them provide the empirically validated full-length sequence
of circRNAs. An exception could be made for single-exon circR-
NAs, as it can be assumed that their sequence is the same as
their parental linear exons. Interestingly, only 1.5% of circRNAs
from the selected databases seem to be single-exon circRNAs.
Whether this is caused by annotation problems in the different
databases or is a true feature of circRNA biogenesis is unclear at
this point.
While some tools, including CIRI-full [51] and circseq_cup
[52], were developed to detect full-length circRNA sequences
based on RNA-seq data, current databases do not make use of
this type of analysis. CIRI-full makes use of a novel feature called
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reverse overlap and of the BSJ sites to reconstruct full-length cir-
cRNAs and circular isoforms.Circseq_cup first identifies BSJ sites
and then assembles the full-length sequences of circRNAs using
the paired-end reads aligned to the BSJ. Apart from computa-
tional methods, full-length circRNAs have been unambiguously
identified using long-read single-molecule sequencing [53] or
rolling circle amplification in combinationwith Sanger sequenc-
ing [54].
Another important characteristic of a circRNA is the DNA
strand from which it is transcribed. Six of the databases we
reviewed (30%) do not report the originating strand. Moreover,
circRNADb does not report the gene nor the strand, but a link
is provided to circBase, where the strand can be found. If the
host gene is not mentioned, it is crucial to mention the strand
from which the circRNA is transcribed (and hence stranded RNA
sequencing methods should be used) to be able to identify the
circRNA correctly.
Ambiguous circRNA nomenclature contributes to the
reproducibility crisis
Until now, no consensus circRNA nomenclature has been
established. As indicated in Table 3, several similar nomen-
clature systems are in use, leading to multiple issues and
increasing the risk of mistakes and confusion. The various
nomenclature systems differ slightly in their prefix and the
number of digits in the index. Next to the same circRNA having
multiple names, nearly identical names with the same index
sometimes correspond to different circRNAs. We illustrate this
issue using circMTO1, which has at least 11 different names
(Table 4). CircMTO1 (hsa_circ_0007874, hg19: chr6:74175931–
74,176,329) is a circRNA that acts as a miRNA sponge for
multiple RNA molecules, including oncogenic miR-9 [11] and is
linked to HCC [55]. circMTO1 is referred to as hsa_circ_30012 in
circRNADb and hsa_circ_0007874 in circBase. It is problematic
that hsa_circ_0030012 is a completely different circRNA in
circBase, transcribed from FAM48A (hg19: chr13:37598171-
37625720) and hsa_circ_07874 in circRNADb is also a completely
different molecule (hg19: chr2:55040368-55047599). Similarly,
while hsa-MTO1_000001 corresponds to a molecule with
a BSJ at position chr6:74175932-74202075 in circAtlas v2.0,
circbank gives other BSJ coordinates to hsa_circMTO1_001,
namely chr6:74175931-74176329 (matching the position men-
tioned in circBase). To further illustrate this issue, a second
example presenting a list of all 13 names given to ciRS-7
(hg19: X_139865339:139866824) can be found in Supplemental
Table 4.
Fortunately, most circRNA databases report the circRNA
alias used in circBase, which was one of the first large circRNA
databases. This is with the exception of circAtlas v2.0, CIRCpedia
v2, CircRiC, circRNADb, CSCD andMiOncoCirc v2.0. The only way
to compare the content of these databases is by using the BSJ
position, which is not convenient.
Until now, the circBase nomenclature (hsa_circ_0000007)
seems to be the most widely used naming system. However,
it would be useful to work with a nomenclature that includes
the host gene name, such as circbank proposes. This makes
the name more human-readable and can prevent mistakes.
We recommend combining the species (e.g. hsa for human),
the nature of the RNA molecule (circ), the official gene symbol
(GENE), a then a unique identifier for each circRNA for that
gene. While this unique identifier could be a simple three-digit
number (from one to the total number of circRNAs identified
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Table 4. Eleven different names of circMTO1 illustrate the reproducibility crisis caused by ambiguous circRNA nomenclature. CircMTO1 is a
well-studied circRNA positioned at chr6:74175931–74,176,329 (hg19). Despite several publications on circMTO1, the circRNA does not have a
universal name in the circRNA databases and is referred to by eleven different identifiers
Name for circMTO1 Used in database
circMTO1 Circ2Disease, circad, CircR2Disease, circRNADisease, LncRNADisease 2.0
hsa_circ_0007874 Circ2Disease, circad, circbank, circBase, CircFunBase, circRNADisease,
exoRBase
hsa_circRNA_104135 Circ2Disease, circad, CircR2Disease
hsa_circ_104135 circad, circRNADisease
hsa_circRNA_0007874 circad, CircR2Disease
hsa_circMTO1_001 circbank
HSA_CIRCpedia_55478 CIRCpedia v2
6_74,175,931_74,176,329_MTO1 CircRiC
hsa_circ_30012 circRNADb
exo_circ_006565 exoRBase
chr6:73466208:73466606:MTO1 MiOncoCirc v2.0
for that gene), it would be more informative to have two indices
(e.g. one to indicate the position of the BSJ and the second one
to indicate the splicing pattern, once the full-length sequence
of that specific circRNA is known). For example, two circRNAs
from the same gene with the same BSJ, but with a different
internal sequence, could be called hsa_circGENE_001_001 and
hsa_circGENE_001_002. CircRNAs from which the full-length
sequence is unknown, could be indicated by the _000 suffix.
Alternatively, the strategy currently used by themiRNA database
miRbase [56] can be applied, where instead of a second index
a letter is used to indicate the full-length sequence. For
example: hsa_circGENE_001a for the first known sequence and
hsa_circGENE_001 for the unknown sequence. Using the gene
symbol of the host gene poses another important issue: the
naming system cannot be applied when the host gene lacks
an official symbol, as is the case for many long noncoding
RNAs (lncRNAs). Another unique identifier could be a hash
that represents the full-length circRNA sequence or the 25
nucleotides flanking the BSJ if the full-length sequence is
unknown. In any case, if a naming system without a host gene
is used, it is crucial to report the strand from which the circRNA
is transcribed, otherwise, the name can again refer to different
circRNAs.
CircRNA annotation is mostly based on assumptions
and predictions
Almost all circRNA databases report at least one type of circRNA
annotation (vide supra), but these annotations should be han-
dled with care. First, circRNA annotations are mostly based on
computational predictions rather than experimental validation.
Second, some sequence-based annotations, such as miRNA and
RBP binding are predicted based on the presumed full-length
sequence of circRNAmolecules. As stated before, the empirically
validated full-length sequence of a circRNA is generally lacking,
and it is often not mentioned if the circRNA sequence used for
prediction is the full-length sequence based on the reference
genome, with or without taking splicing into account, or if the
sequence is based on RNA-seq reads containing the BSJ. Third,
it is important to note that the mere detection of a circRNA
in a specific tissue or cell type does not necessarily indicate
that this circRNA is specifically expressed. This also goes for
curated circRNA databases, where the up- or downregulation of
a circRNA in a specific disease sample in comparison with a
control is often used to label a circRNA disease-specific.
Finally, a lot of databases do not report the source of their
annotations and predictions. Overall, we would like to warn
users of circRNA databases to be aware of the limitations regard-
ing circRNA annotations.
Updates, user interface and availability
Although almost all authors of circRNA database articles
mention the importance of regular updates and promise to
maintain their database, only circBase and CIRCpedia v2 seem
to have been updated after publication (in July 2017 and July
2018, respectively). Of note, some databases are very recent at
the time of writing and might be updated in the near future.
Unfortunately, some databases were completely inaccessible
online, and some database exports were incomplete. Also, some
databases are difficult to use or are limited to specific web
browsers.
Conclusions
In this review,we provide an overviewof all databases focused on
human circRNA, divided into noncurated and curated circRNA
databases. In total, there are more than 2 million different cir-
cRNAs present in the union of all noncurated databases, and
3522 circRNAs in the union of all curated databases. Generally
speaking, there is limited overlap among these databases. The
lack of overlap between noncurated databases can be explained
by the use of different samples and the nature of circRNAs (low
abundance, high sample-specificity) on the one hand, and by
varying sequencing methods, circRNA detection tools and filter-
ing on the other hand. It is important to be aware of the sample-
specificity of circRNAs, and a database should be selected with
care when conducting circRNA research. The lack in overlap
among the curated databases might be due to different filtering
techniques when selecting literature, and due to annotation-
related issues. Furthermore, the use of different nomenclature
systems is leading to redundancy and could cause confusion
amongst circRNA researchers. This issue may very well con-
tribute to the reproducibility crisis, and therefore we propose
clear future guidelines for a solid circRNA nomenclature. Also, it
is crucial to realize that the circRNA BSJ is not a unique identifier
of a specific circRNAmolecule, as splicing needs to be taken into
account aswell.Due to the lack of full-length circRNA sequences,
multiple sequence-based annotations are predicted based on the
assumption that circRNAs following the same splicing pattern
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as their parental mRNA counterparts and are thus unreliable.
Finally, several databases are not regularly updated or suffer
from connectivity issues.
Key Points
• There is limited overlap among circRNA databases, a
result of the different source material and the nature
of circRNAs (low abundance, high sample-specificity)
on the one hand, and of varying sequencing methods,
circRNA detection tools and filtering on the other hand.
• The ambiguous nomenclature of circRNAs resulted in
conflicting names for circRNAs in different databases,
contributing to the reproducibility crisis. One uniform
naming system should be carefully implemented to
prevent further future confusion.
• The BSJ position on itself is not sufficient to uniquely
identify a circRNA, and the full-length sequence ofmost
circRNAs is lacking.
• Many circRNA databases report interactions with
miRNA and RBPs, protein-coding potential, conserva-
tion between species, etc. These predictions should be
used with caution, as they are generally based on the
assumed full-length sequence of circRNAs.
Supplementary Data
Supplementary data are available online at https://academic.
oup.com/bib.
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